Cost Utility Analysis of BPJS and Non-BPJS Dyspepsia Patients Combination of Ranitidine Antacids with Lansoprazole Antacids

Authors

  • Aas Saadah 4Fakultas Farmasi Universitas Pancasila, Jl. Srengseng Sawah Jagakarsa, Jakarta Selatan 12640
  • Prih Sarnianto Universitas Pancasila, Jl. Srengseng Sawah Jagakarsa, Jakarta Selatan 12640
  • Hesti Utami R. Universitas Pancasila, Jl. Srengseng Sawah Jagakarsa, Jakarta Selatan 12640
  • Irmin Universitas Pancasila, Jl. Srengseng Sawah Jagakarsa, Jakarta Selatan 12640

DOI:

https://doi.org/10.25311/keskom.Vol8.Iss2.1234

Abstract

Cost Utility is an analysis method of farmacoeconomy which compares the treatment cost with the patient’s life quality, dyspepsa is a relapse disease so it needs repetition medication which improve healthy cost and influence the patient’s life quality. This study is aimed to know the benefical of cost and the patient’s life quality which uses BPJS and Non BPJS from the combination of generic ranitidin antasida active substance with generic branded ranitidin antasida and generic lansoprazol antasida. This study was done as observational prospective during three months through structured interview at Insani Clinic with the 200 respondents which divided four groups, the respondent is the dyspesia patients which have visited medical history a dyspesia treatment at the clinic. Kruskal Wallis analysis was used to see differences in the quality of life of patients in the four groups, after which the Mann Whitney follow-up test and Cost Utility analysis were performed. The result of this study showed that based on Mann Withney test, it is obtained that there is difference of life quality toward four groups and cost utility analysis obtained from the comparison of generic medicine and generic branded wih the combination of antasida and ranitidin obtained is G1 about Rp 3.859 per QALYs with B1 about Rp 38.666 per QALYs with RIUB Rp 286.242, G2 about Rp 8.605 with B2 about Rp 68.788 with RIUB Rp 610.439, therefore it was obtained respondent is afford to pay more to get better life quality toward dyspesia disease at the clinic.

Downloads

Download data is not yet available.

References

Mahda, R. (2018). Faktor - faktor yang berhubungan dengan dispepsia pada remaja SMA di Bogor. IPB, Departemen Gizi Masyarakat.

Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology. 2005 Nov;129(5):1756-80. doi: 10.1053/j.gastro.2005.09.020. PMID: 16285971.

Miwa, H., Ghoshal, U. C., Gonlachanvit, S., Gwee, K. A., Ang, T. L., Chang, F. Y., Fock, K. M., Hongo, M., Hou, X., Kachintorn, U., Ke, M., Lai, K. H., Lee, K. J., Lu, C. L., Mahadeva, S., Miura, S., Park, H., Rhee, P. L., Sugano, K., Vilaichone, R. K., … Bak, Y. T. (2012). Asian consensus report on functional dyspepsia. Journal of neurogastroenterology and motility, 18(2), 150–168. https://doi.org/10.5056/jnm.2012.18.2.150

Lacy BE, Talley NJ, Camilleri M. Functional dyspepsia: time to change clinical trial design? The American Journal of Gastroenterology. 2010 Dec;105(12):2525-2529. DOI: 10.1038/ajg.2010.266. PMID: 21131922.

Kementeriaan Kesehatan .2007. Pusat data dan Informasi Profil Kesehatan Indonesia tahun 2006.Depkes RI : Jakarta

Kementeriaan Kesehatan .2012. Pusat data dan Informasi Profil Kesehatan Indonesia tahun 2011.Depkes RI : Jakarta

Omega , A. (2010). Prevalensi dispepsia pada pasien dewasa di RSCM Jakarta pada tahun 2010 dan faktor – faktor yang berhubungan. Jakarta, Universitas Indonesia.

Hanifah, S. (2019). 8 Penyakit ini bikin anggaran BBPJS Jebol. Retrieved from https://www.merdeka.com/uang/8-penyakit-ini-bikin-anggaran-bpjs-kesehatan-jebol.html diakses 12 Desember 2019.

Dyah, A. (2010). Dasar - dasar farmakoepidemiologi. Yogyakarta, Imperium.

Khoiriyah, S.D. (2018). Review Artikel: Kajian Farmakoekonomi Yang Mendasari Pemilihan Pengobatan Di Indonesia. Farmaka, 16(3), 134-145. DOI : https://doi.org/10.24198/jf.v16i3.17435

Babaeian M, Naseri M, Kamalinejad M, Ghaffari F, Emadi F, Feizi A, Hosseini Yekta N, Adibi P. Herbal Remedies for Functional Dyspepsia and Traditional Iranian Medicine Perspective. Iran Red Crescent Med J. 2015 Nov 7;17(11):e20741. doi: 10.5812/ircmj.20741. PMID: 26734483; PMCID: PMC4698144.

Talley NJ, Vakil N; Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia. Am J Gastroenterol. 2005 Oct;100(10):2324-37. doi: 10.1111/j.1572-0241.2005.00225.x. PMID: 16181387.

Irawan,D,2007.Stress dan Reaksi Tubuh. http://www.ahlinyalambung.com

Sugiyarto OK, Probosuseno, Sari IP. (2014). Perbandingan Kualitas Hidup Pasien Dispepsia yang Menggunakan anprazol dengan Injeksi Raniditin. Jurnal Manajemen dan Pelayanan Farmasi, 4(3), 180-184. https://doi.org/10.22146/jmpf.285

Silviarizka RF, Sholihat NK, Pratiwi H. (2019). Analisis Efektifitas Biaya Penggunaan Omeprazol vs Raniditin sebagai Profilaksis Tekanan User di ICU RSUD Dr. Margono Soekarjo Purwokerto. Acta Pharm Indo, 7(2), 80-89. DOI. 10.5281/zenodo.3707607

Aini, N. (2019). Pola Penggunaan Obat Pada Pasien Dispepsia Rawat Inap di RSUD AEK Kanopan Kab. Labuhan Batu Utara. Medan, Universitas Sumatra Utara.

Syahputra F. (2012). Perbandingan Lanprazol dan Raniditin dalam Pengobatan Dispepsia Fungsional pada Remaja. Medan, Universitas Sumatra Utara.

Sholihah NA, Oetari, Sunarti. (2019). fektivitas Biaya Penggunaan Lanprazole Dan Ranitidin Pada Pasien Gastritis. VIVA MEDIKA: Jurnal Kesehatan, Kebidanan, dan Keperawatan , 12(1), 86-96. DOI: https://doi.org/10.35960/vm.v12i01

Hutahaehan AV, Citraningtyas G, Wewengkang DS. (2019). Analisis Efektivitas Biaya Pada Pasien Gastritis Rawat Inap Di Rumah Sakit Bhayangkari Manado. PHARMACON, 8(4), 767-773. DOI: https://doi.org/10.35799/pha.8.2019.29351

Herman, Lau, SHA. (2020). Faktor Resiko Kejadian Disepsia. Jurnal Ilmiah Kesehatan Sandi Husada, 9(2), 1094-4563. DOI 10.35816/jiskh.v10i2.471

Submitted

2022-05-19

Accepted

2022-06-23

Published

2022-08-31

How to Cite

1.
Saadah A, Sarnianto P, Utami R. H, Irmin. Cost Utility Analysis of BPJS and Non-BPJS Dyspepsia Patients Combination of Ranitidine Antacids with Lansoprazole Antacids. J Keskom [Internet]. 2022 Aug. 31 [cited 2023 Jan. 28];8(2):352-61. Available from: https://jurnal.htp.ac.id/index.php/keskom/article/view/1234